PARP1 and prostate cancer: In this issue of the JCI, Köcher et al. have demonstrated that ERG overexpression in human prostate cancer cells rewired DNA double-strand break repair toward a poly(ADP-ribose) polymerase 1-dependent (PARP1-dependent) alternative end-joining pathway without disrupting canonical repair.